MISTRAS (MG) Q4 2025 earnings review
Top-Line Rebounds and Margins Expand, But Cash Conversion Collapses
MISTRAS achieved a significant milestone in Q4: a return to revenue growth (+5.1% YoY) combined with aggressive gross margin expansion (+190 bps). This dynamic drove a record fourth-quarter Adjusted EBITDA of $24.8 million (+18.2% YoY). However, the bottom line tells a messier story. GAAP Net Income dropped 26% due to high reorganization costs, and full-year Free Cash Flow collapsed to just $3.8 million (down 86% YoY) as ERP implementation issues severely bloated accounts receivable. The core business is gaining operating leverage, but cash conversion is currently broken.
🐂 Bull Case
The company's pivot away from cyclical Oil & Gas is accelerating. Q4 Aerospace & Defense revenues surged 21.7% YoY, and Power Generation skyrocketed 33.2%. MISTRAS is successfully finding higher-margin growth in new end markets.
Gross margins expanded by 190 basis points in both Q4 (28.4%) and the Full Year (28.2%). Record FY25 Adjusted EBITDA of $91.1M proves that recent organizational delayering and lab consolidations have established a more profitable baseline.
🐻 Bear Case
FY25 Free Cash Flow plummeted to $3.8M from $27.1M in FY24. An ERP implementation rollout earlier in the year caused invoicing delays, swelling Accounts Receivable by $27.4M and suffocating cash generation.
Despite growth elsewhere, the massive Oil & Gas vertical remains a laggard. Q4 revenues declined 5.4% YoY to $91.8M, proving that this historical core remains a persistent drag on the top line.
⚖️ Verdict: ⚪
Neutral. The operational trajectory is clearly positive with accelerating margin profiles and robust growth in non-O&G markets. However, until management proves they can fix the ERP-driven working capital drag and normalize cash flow, the stock's upside is constrained.
Key Themes
Aerospace & Power Gen Diversification Accelerating
MISTRAS's strategic push to dilute its Oil & Gas dependency is yielding excellent results. In Q4, Aerospace & Defense grew 21.7% to $25.2M, and Power Generation & Transmission surged 33.2% to $13.3M. This shift toward higher-complexity, mission-critical environments is a primary driver for the company's 190 bps gross margin expansion.
Working Capital Drag Paralyzes Cash Flow
The company's Free Cash Flow is reversing violently. FCF for FY25 fell to $3.8M from $27.1M in FY24. The culprit is a massive buildup in Accounts Receivable, which jumped to $154.7M from $127.3M. This stems directly from invoicing delays tied to an April 2025 ERP cutover that management has still not fully resolved, severely limiting the ability to pay down debt.
Reorganization Costs Weighing on GAAP Earnings
While non-GAAP metrics look fantastic, actual GAAP Net Income fell to $3.9M in Q4 (down from $5.3M YoY). This was driven by elevated 'Reorganization and other costs', which hit $4.9M in Q4 and $12.7M for the full year. Management continues to spend heavily to recalibrate overhead and execute voluntary lab consolidations under CEO Natalia Shuman.
Oil & Gas Market Lags the Recovery
Decelerating demand in the core Oil & Gas market remains the primary anchor on total revenue growth. Q4 O&G revenue contracted 5.4% YoY to $91.8M, bringing full-year segment revenue down by $22.1M compared to FY24. Softness in Midstream customer budgets and turnaround scheduling continue to pressure this vertical.
Other KPIs
Accelerating significantly. Up 160 basis points compared to 24Q4. The expansion reflects structural improvements: closing underperforming labs and pushing higher-margin Data Solutions (PCMS) and A&D contracts.
Reversing the deleveraging trend. Gross debt grew from $169.6M at the end of FY24. The weak operating cash flow generation completely stalled management's stated priority of using free cash flow for debt reduction. However, the bank leverage ratio remains healthy at 2.5X.
Guidance
Management withheld specific numerical guidance in the earnings release, stating that the 2026 outlook will be provided during the scheduled conference call. The Board noted that 2026 will be a 'targeted year' with increased investments to accelerate strategy, which may imply heavier CapEx or muted near-term profitability in favor of long-term tech differentiation.
Key Questions
Accounts Receivable Normalization
The ERP implementation in April severely bloated Accounts Receivable and crushed FY25 Free Cash Flow. When exactly will invoicing catch up, and what is the target FCF conversion rate for FY26?
2026 'Accelerated Investments'
The Board views 2026 as a year to 'accelerate our strategy via increased investments.' Does this imply higher CapEx, elevated M&A activity, or a step back in Adjusted EBITDA margins next year?
Timeline for Reorganization Costs
Reorganization costs more than doubled to $12.7 million in FY25. Are the bulk of these structural cuts and lab consolidations complete, or should investors model elevated restructuring charges into FY26?
Oil & Gas Outlook
With Oil & Gas revenues shrinking 5.4% in Q4, are we seeing structural demand destruction, or is this primarily tied to delayed turnarounds that will eventually reverse?